ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Interventional Cardiology

Top Interventional Cardiology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JUAN CUETO MD

Interventional Cardiology

25,187

$1.56M

1347
1250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $66

CANDIDO DIAZ-CRUZ M.D.

Interventional Cardiology

15,432

$773K

492
475 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $66

ADEL SIDKY M.D.

Interventional Cardiology

10,597

$928K

469
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $66

FERNANDO DEARMENDI M.D.

Interventional Cardiology

10,281

$476K

444
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 29%

$46
Average prescription price

Avg: $66

RAMON LLORET MD

Interventional Cardiology

10,181

$779K

787
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $66

FRANCISCO DIEGUEZ MD

Interventional Cardiology

9,452

$444K

1174
1048 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $66

NANDKISHORE RANADIVE M.D.

Interventional Cardiology

9,352

$485K

1121
970 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $66

ALAND FERNANDEZ MD

Interventional Cardiology

9,333

$447K

1006
919 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 29%

$48
Average prescription price

Avg: $66

MANUEL MAYOR MD

Interventional Cardiology

7,366

$613K

341
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $66

RAYMOND LICCINI M.D.

Interventional Cardiology

7,204

$351K

713
627 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$49
Average prescription price

Avg: $66

ABDUL-RAHMAN JARAKI MD

Interventional Cardiology

7,190

$657K

227
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $66

EDUARDO SABATES MD

Interventional Cardiology

6,576

$339K

477
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $66

BERNARDO STEIN MD

Interventional Cardiology

6,034

$380K

601
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $66

ASHRAF ELSAKR M.D.

Interventional Cardiology

5,858

$384K

442
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $66

SANDEEP BAJAJ M.D.

Interventional Cardiology

5,840

$414K

527
425 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $66

STEVEN MALOSKY MD

Interventional Cardiology

5,604

$283K

447
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $66

HECTOR GARCIA M.D.

Interventional Cardiology

5,595

$318K

796
744 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $66

ALVARO GOMEZ MD

Interventional Cardiology

5,541

$337K

363
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $66

WILLIAM DOTY MD

Interventional Cardiology

5,297

$363K

477
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $66

EDWIN ROGERS MD

Interventional Cardiology

5,231

$437K

481
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $66

BIJU MATHEWS MD

Interventional Cardiology

5,152

$365K

581
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $66

STEVEN KARAS MD

Interventional Cardiology

5,120

$383K

574
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$75
Average prescription price

Avg: $66

FRANCISCO PALACIOS MD

Interventional Cardiology

4,946

$303K

354
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $66

BABAK VAKILI MD

Interventional Cardiology

4,876

$358K

589
482 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $66

DAVID JURKOVICH MD

Interventional Cardiology

4,719

$220K

294
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $66

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank